Global poliomyelitis eradication: status and implications

Lancet

Volumn 369, Issue 9570, 2007, Pages 1321-1322

  Fine, Paul EM ^a   Griffiths, Ulla Kou ^a  

^a LONDON SCHOOL OF HYGIENE AND TROPICAL MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ORAL POLIOMYELITIS VACCINE;

ARTICLE; DRUG EFFICACY; ECONOMIC ASPECT; ERADICATION THERAPY; HEALTH PROGRAM; IMMUNIZATION; POLIOMYELITIS; PRIORITY JOURNAL; VIRUS TRANSMISSION;

EID: 34247150640     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(07)60533-9     Document Type: Note

References (12)

1. WHO. Conclusions and recommendations of the Advisory Committee on Poliomyelitis Eradication, Geneva 11-12 October 2006, part I. Wkly Epidemiol Rec 81 (2006) 453-460
2. WHO. Conclusions and recommendations of the Advisory Committee on Poliomyelitis Eradication, Geneva 11-12 October 2006, part II. Wkly Epidemiol Rec 81 (2006) 465-468
3. Grassly N., Fraser C., Wenger J., et al. New strategies for the elimination of polio from India. Science 324 (2006) 1150-1153
4. Kew O., Sutter R., de Gourville E., Dowdle W., and Pallansch M. Vaccine-derived polioviruses and the endgame strategy for global polio eradication. Ann Rev Microbiol 59 (2005) 587-635
5. MacLennan C., Dunn G., Huissoon A., et al. Failure to clear persistent vaccine-derived neurovirulent poliovirus infection in an immunodeficient man. Lancet 363 (2004) 1509-1513
6. Dowdle W., van der Avoort H., de Gourville E., et al. Containment of polioviruses after eradication and OPV cessation: characterising risks to improve management. Risk Anal 26 (2007) 1449-1469
7. Arita I., Nakane M., and Fenner F. Public health: is polio eradication realistic?. Science 312 (2006) 852-854
8. Grassly N., Wenger J., Durrani S., et al. Protective efficacy of a monovalent oral type 1 poliovirus vaccine: a case control study. Lancet (2007). published online April 12, 2007. DOI:10.1016/S0140-6736(07)60531-5
9. Thompson K., and Tebbens R.D. Eradication versus control for poliomyelitis: an economic analysis. Lancet (2007). published online April 12, 2007. DOI:10.1016/S0140-6736(07)60532-7
10. Fine P., and Carneiro I. Transmissibility and persistence of oral polio vaccine viruses: implications for the global polio eradication initiative. Am J Epidemiol 150 (1999) 1001-1021
11. Fine P., Sutter R., and Orenstein W. Stopping a polio outbreak in the post-eradication era. Dev Biol 105 (2001) 129-147
12. GAVI. Annex 1: 2007-10 GAVI roadmap (Nov 11, 2006). http://www.gavialliance.org/resources/2007_10_Roadmap_final.pdf (accessed April 4, 2007).